Prescription drug wholesaler pleads guilty to smuggling counterfeit cancer drugs
The FDA recently reported that the owner of a Turkish drug wholesaler has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States. Sabahaddin Akman, owner of the Turkish firm Ozay Pharmaceuticals, pleaded guilty in the U.S. District Court for the Eastern District of Missouri, to smuggling counterfeit cancer drugs including multiple shipments of Altuzan, the Turkish version of bevacizumab (Avastin, Genentech).
The drugs did not meet FDA standards and had not been approved for distribution in the United States. The FDA’s Office of Criminal Investigations organized an international investigation that led to Akman’s arrest in Puerto Rico in January 2014. The investigation identified Akman and his company as a source of Altuzan.
Related Posts
Fake Domestic Products Push Chinese Consumers to Shop Overseas
SEOUL, Jan.26 (Korea Bizwire) – The Chinese Spring Festival, which is the biggest...
Two million smuggled cigarettes seized at Dublin Port
Revenue officers, acting on intelligence, commenced an examination of a shipping...
One held for manufacturing, supplying fake fertilisers in Madhya Pradesh
JABALPUR: A man has been arrested here for allegedly manufacturing and supplying...
Russians Drank 10M Litres of Counterfeit Whiskey in 2013
Russian retailers sold 9.9 million litres of whiskey more than the country...